There are several ways to support the QiC Programme, and partners have the opportunity to help develop the programme alongside NHS and patient group experts.
QiC partners will benefit from exclusive networking opportunities with experts in the therapy area landscape over the lifecycle of each award programme.
"Sanofi is pleased to support the QiC Programme in 2020 and to recognise those individuals, teams, Trusts and partnerships who demonstrate quality in care for people living with diabetes. We’re keen to see evidence of quality improvement which aligns with current NHS priorities reinforced in the NHS’ January 2019 long term plan. These include reducing variation in access and quality of care to minimise risk of complications, improving achievement of NICE treatment targets, expanding provision of structured education including digital self-management tools and ensuring hospitals provide access to multidisciplinary teams to improve recovery, reduce length of stays and future admission rates."
Professor Mike Baxter, Diabetes Therapy Lead, Sanofi Medical